Clinical use is off-label and investigational, and it belongs under the supervision of a licensed provider who knows your history and can order labs
ISSN 1354-3776
If you are taking the weekly Wegovy injection, the typical starting dose for new patients is .25mg
Reason for use: Diabetes, obesity, or another approved indication
In the DURATION-8 trial, dapagliflozin as monotherapy and in combination with EX-QW showed trends favoring improvements in LFC, glucose and lipid metabolism, and liver fibrosis scores at the end of the study, but no significant statistical differences were observed
It describes three actions: triggering insulin production, reducing glucagon release, and decelerating stomach emptying, which together support better blood sugar management